Mikhail Blagosklonny is an American oncologist who specializes in cancer and aging. He is devoted to cancer research and always targets cancer therapies that protect the healthy body cells from damage. Mikhail Blagosklonny is also the editor in chief of adding, as well as the assistant editor of therapy and Cancer Biology. He always focuses on ensuring that people living with cancer are well taken care of, and they are given proper medication Mikhail Blagosklonny is a member of the board the edits cell death and differentiation at https://en.wikipedia.org/wiki/Mikhail_Blagosklonny. He is also an author of medical search articles and also book chapters that explain more about the research he has conducted.
Mikhail Blagosklonny graduated with a master’s degree in internal medicine from the First Pavlov State Medical University of St. Peterburg and did his Ph.D. in Cardiology and experimental medicine from the same University. He after that became an assistant professor of medicine at New York Medical College before been a scientist at Ordway Research Institute which situated in Albany New York. Mikhail Blagosklonny was then appointed a professor of oncology at Roswell Park Cancer Institute in the year 2009 and is still teaching. He is currently doing research about anti-aging drugs and the underlying mechanism of aging, as well as cancer therapies that protect normal cells from damage.
Mikhail Blagosklonny is considered the most passionate advocate for rapamycin in old age research on nature.com, this is after he developed a hypothesis about the role of TOR signaling in aging and came up with rapamycin, a well-known cancer drug as a possible cure for life extension. The primary aim of this research was to help the aging live more years. He works very hard in all his research to make sure that the outcomes are acceptable and also helpful to the people. He is always focused in all he does specifically in his field as a professor on impactjournals.com who nurtures and teaches students to become better oncologists in the United States.
Mikhail as a professor ensures that the students get to know all about cancer and how they are supposed to treat it. He also ensures that the general public is well informed about cancer and what causes the disease. Mikhail Blagosklonny goes on and assists the aging by providing them with drugs that assists in age-related diseases. Mikhail also reveals the potential targets for slowing down aging such that one do not look old as he may be.